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This study assessed the association between respiratory symptoms and mortality in four cohorts of 
the general population in Norway aged 15–75 years and in selected subgroups in the pooled 
sample.  
Methods 
The study comprised 158,702 persons, who were drawn randomly from the Norwegian population 
register. All subjects received a standardized, self-administered questionnaire on 11 respiratory 
symptoms between 1972 and 1998, with follow-up of death until 31 December 2017.  Analyses 
were performed on 114,380 respondents, 
Results 
The hazard of death was closely associated with gender, age, and education. The hazard ratios 
(HR) for death and the 95 % confidence intervals (CI) by risk factors were similar in the four 
cohorts. After adjustment for demographic and environmental, modifiable factors, the HR for death 
was 1.90 (95% CI 1.80–2.00) for breathlessness score 3, 1.28 (1.21–1.37) for cough/phlegm score 
5 and 1.09 (1.05–1.14) for attack of breathlessness/wheeze score 2 compared to the referent (no 
symptom), respectively. The cough/phlegm score was associated with death in current smokers 
but not in never smokers or ex-smokers. Breathlessness score was associated with death in men 
and women..  
Conclusions 
Among persons aged 45-75 years, respiratory symptoms were significant predictors of all cause 
mortality. Education and smoking habits influenced only the associations between coughing and 
mortality. The associations were independent of study sites. 





Respiratory symptoms are one of the most frequent reasons to contact health care practitioners. 
They are common in all populations, and the prevalence of respiratory symptoms and their 
determinants have been studied extensively for more than 60 years [1-4]. Respiratory symptoms 
may represent different pathophysiological mechanisms and diseases. Asthma, COPD and chronic 
bronchitis are common causes, as well as upper and lower acute airway infections, allergic 
diseases, cardiovascular diseases, restrictive lung diseases and other diseases. The mortality for 
persons with persistent cough and phlegm has been examined since 1964 [5] and for up to 30 
years [6-9] in a defined geographical area. The risk of death is higher for effort-related 
breathlessness and chronic mucus hypersecretion than for asthmatic symptoms [6-10] 
 
Previous studies on the association of respiratory symptoms with mortality have adjusted for 
gender, age, smoking, sometimes occupational exposure, but to our knowledge rarely for 
educational level. Socioeconomic status (SES) is associated with the prevalence of many disease, 
including COPD [11, 12], and is associated with mortality [13], although the mechanisms are not 
clear [14]. This association may be indirect and mediated through both behavioral, environmental 
and genetic factors. In Norway and many other countries, education is often used as a proxy for 
SES. Education is also an important predictor of presence of respiratory symptoms and obstructive 
lung disease independent of smoking and occupational airborne exposure in our communities [15, 
16]. 
 
No studies on mortality are available on ordinal ratings of breathlessness, mucus hypersecretion 
and asthmatic symptoms with follow up time of more than 30 years and for different geographical 
areas within a country.  
 
The objective was to determine the association between respiratory symptoms in four cohorts, in 
pooled cohorts and in strata according to sex, age, education, and smoking status. We 
hypothesized that self-reported respiratory symptoms in the community are strong predictors of 
death; and wanted to conduct i) stratified analysis by smoking habits and ii) educational level, as 
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well as assess the predictive value of respiratory symptoms over 45 years. 
 Methods 
Study populations 
The study populations were derived from four cross-sectional surveys in the city of Oslo 1972 and 
1998–1999, Hordaland County in 1985, 1988–1989 (including Sauda municipality in Rogaland 
county) and 1998–1999 [17]. Oslo is the capital of Norway with an urban population with 477,476 
persons in 1972 and 499,693 persons in 1998. Hordaland county in Western Norway is a 
combined rural and urban (Bergen) population with 399,702 persons in 1985, 405,063 in 1988 and 
428,823 in 1998. Sauda is a rural municipality in Rogaland county with 5,416 persons in 1988. 
 
The target populations were born 1902–1973. The sample frames were updated lists from the 
Norwegian Central Population Registry. Invitees were drawn at random for the 1972, 1985 and 
1998–1999 surveys. The 1988–1990 survey invited all men born 1914–1958, plus a 10 % sample 
of the general population of city of Bergen examined in 1965–1970, leading to about 6 % women in 
this cohort. In the analyses, those included in one cohort were excluded from the later cohorts. The 
sampling frames comprised 158,702 persons. In the statistical analyses presented here, we 
included respondents who provided information on smoking status, altogether 114,380 persons 
(72 %). For details, see Table 1. 
 
The study was approved by the Committee on Medical Research Ethics, The Norwegian Data 
Inspectorate and The Norwegian Directorate of Health 
 
Questionnaire 
A group of five chest physicians and one epidemiologist developed a self-administered 
questionnaire in 1972. The questionnaire was a modification of one approved by the British 
Medical Research Council`s Committee on Research into Chronic Bronchitis in 1966. The 
validity of the Norwegian respiratory questionnaire has been examined by lung function levels and 
bronchial responsiveness [18], and the lack of agreement with the original British Medical 
Research Council questionnaire has been examined [19]. The self-reported respiratory symptoms 
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poorly predicted airflow limitation measured by spirometry, as well as bronchial hyper-
responsiveness measured by metacholine provocation test. 
 
The questionnaire included 11 questions about respiratory symptoms (Table 2), covering current 
cough, phlegm, wheezing, periods of cough and/or phlegm and breathlessness, which were 
aggregated into three symptom groups. Individuals giving affirmative answers to the 
breathlessness questions 13–16 were given symptom scores 1 to 4; affirmative answers to the 
cough and/or phlegm questions 8–12 were given symptom scores 1 to 5, and affirmative answers 
to the attacks of breathlessness and wheezing questions 17–18 were given symptom scores 1 to 
2. 
 
The questionnaire included also questions on smoking history [20] and occupational exposure to 
air pollution. Smoking was categorized as: current smokers (at the time of the study), ex-smokers 
(had smoked daily but had quitted) or non-smoker (had never smoked daily). Tobacco consumption 
was estimated from number of cigarettes (1 cigarette = 1 g). The daily tobacco consumption was 
grouped as <10 g, 10–19 g and ≥20 g. Occupational exposure to air pollution was defined by an 
affirmative answer to the question: “Have you been exposed to particles, gases or damp at your 
working place?”  
 
Follow-up 
Date of death and emigration until 31 December 2017 and education were obtained from the cause 
of Death Registry of the National Institute of Public Health and a linkage to a copy of the National 
Population Registry of the Norwegian Tax Administration. All inhabitants of Norway have a unique 
personal identification number that allows complete follow-up until death or emigration. In total, 
156,896 people were observed, median follow-up was 26.7 years, maximum 45.2 years. The 
cumulative time for observation in the total sample was 3,541,219 person-years. A total of 114,380 
respondents with known smoking status were observed, median follow-up was 27.3 years, 




Highest attained education was extracted from the national census for each decade and converted 




Descriptive statistics for the participants and symptom scores for breathlessness on effort, cough 
or/and phlegm and attacks of breathlessness or/and wheeze in the four cohorts are presented in 
frequency tables as number (%). For start dates for observations in the cohorts, we used 5 October 
1972 in the Oslo county 1972 cohort, the 15th of the actual starting month in the Hordaland county 
and Sauda municipality, Rogaland county cohort 1988–1990, and the actual start date in the other 
two cohorts. Other missing start dates for respondents to the questionnaires were imputed using 
the median start date in the same cohort: 31 December 1989 in the Hordaland county and Sauda 
municipality, Rogaland county cohort 1988–1990 (n=100) and 5 October 1998 in the Oslo and 
Hordaland counties cohort 1998–1999 (n=4). Respondents with negative times to event or 
censoring, for example having emigrated before responding to the questionnaire or dying before an 
assigned median start date were excluded. The cohort members were followed until death or 
censored at the date of emigration or end of follow-up on 31 December 2017. For some people 
that emigrated (n=231), we did not have an exact date of emigration, but only an interval. These 
cases were censored at the mid-point of the interval.  
 
We did not impute missing values for other variables than the start date and the date of emigration. 
Among the respondents included, we had complete data on age, sex, smoking status, 97.5 % had 
complete data on education, and 93.8% on occupational exposure as well. 
 
All analyses were multivariable, adjusting for sex, age (continuous variable), education (<10, 11–
13, ≥14 years), smoking habits (never, ex-, current-smoker) and occupational exposure (dust/fume 
vs. none). The results are presented as hazard ratios (HR) of death with 95% confidence intervals 
(CI). The four cohorts were pooled, and the association of symptom scores of breathlessness on 
effort, cough or/and phlegm and attacks of breathlessness or/and wheeze with all-cause mortality 
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in the total pooled cohort and in subgroups was analyzed using multivariable Cox proportional 
hazards analysis, entering symptom scores of breathlessness on effort, cough or/and phlegm and 
attacks of breathlessness or/and wheeze simultaneously into the models. We used time on study 
as the dependent variable in the Cox models. These analyses were prepared using shared frailty 
for study cohort, i.e. incorporating cluster‐specific random effects to account for within‐cluster 
homogeneity in outcomes [21]. 
 
We conducted analyses for subgroups according to sex, age (15–29, 30–44, 45–59, ≥60 years), 
education, and smoking status using a similar approach with shared frailty for study cohort.  
 
The proportional hazards assumption was checked graphically using log-log plots and was 
considered acceptable. We chose a significance level of 0.05 using two-sided tests. Stata version 




Study participants and response rates 
The response rates of those invited for the four surveys declined from 89 % in the survey in Oslo 
1972 to 67 % in the survey of Oslo and Hordaland county in 1998. From 1972 to 1998, the 
proportion of respondents with higher education and those reporting occupational exposure to air 
pollution increased, while the proportion of smokers decreased (Table 3).  
 
Respiratory symptoms 
Of the respondents, 20 % reported breathlessness on effort, 35 % cough or phlegm and 25 % 
wheeze or attacks of breathlessness (Table 4). A larger proportion of respondents reported 
respiratory symptoms in 1998 in Oslo and Hordaland counties compared to the 1972 and 1985 





The prevalence of cough and phlegm did not differ between never smokers and ex-smokers (Table 
5). However, breathless on effort, attacks of breathlessness and wheeze were more prevalent in 
current smokers than never smokers.  
 
Mortality 
Altogether 45,835 respondents died during follow up. The overall HR of death for respondents 
versus non-respondents was 0.64 (95%CI 0.63–0.65) after adjustment for gender, age and 
education (Supplement, Table 1). The pattern of increasing HR of death in men, by higher age and 
lower attained education were identical for the four cohorts (data not shown).  
 
Respiratory symptoms and mortality 
Cohorts 
Respiratory symptoms were associated with death in all four cohorts, although more consistent 
across cohorts for breathlessness on effort than for cough and phlegm (Table 6). No clear 
association was observed between deaths and attacks of breathlessness and wheezing. The HR 
of breathlessness score 4 was not statistically significant from that of breathlessness score 3. An 
increased HR with higher symptom scores for cough and phlegm was only observed in two of the 




The HR of death in the pooled cohorts increased with number of positive symptoms in all three 
symptom groups except for breathlessness on effort score, where the HR ratio for death was 
similar for score 3 and 4 (Table 7). The HR was weakened only for cough and phlegm by 
adjustment for smoking and education. In stratified analyses, the breathlessness score was 
associated with death in men and women.  
 
The risk of death by respiratory symptoms were almost identical in the strata according to highest 
attained education (Supplement, Table 2). The HR of death was similar across most levels of the 
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cough and phlegm scores in never smokers and ex-smokers, but unambiguous among current 
smokers (Supplement, Table 3). The symptoms of attacks of breathlessness and wheeze were 
poor predictors of death.  
 
There was an increased HR of death by higher scores of breathlessness on effort for those 
aged >30 years, but no apparent trend for those aged 15–29 years. Except for the age group 15–
29 years the risk of death was higher for breathlessness score 3 than score 4, although statistically 
not significant (Supplement, Table 4). Cough and phlegm scores were associated with increased 
mortality except for the age group <30 years. Attacks of breathlessness and wheeze showed little 
association with death in the age strata, except among those aged 45–59 years.  
 
Follow up time 
In a Kaplan-Meier plot (Fig. 1), the HR of death increased with increasing load of respiratory 
symptoms for breathlessness on effort and for cough and phlegm, and asthma attacks and 




In long-term follow up of four general population surveys between 1972 and 1998, we have found 
associations of respiratory symptoms with mortality, with higher hazards of death with increasing 
symptom load. The pooled cohort, comprised subjects with the age span 15 to 75 years living in 
urban as well as rural areas. The pattern of associations was similar across the four cohorts, which 
supports the robustness and external validity of the findings. The association of breathlessness on 
effort with death was present in strata according to age, sex, level of education, and smoking 
status. Cough and phlegm score was similarly associated with death in strata according to sex, 
education, age >29 years and in current smokers, but not in ex-smokers and never smokers. In 
contrast, there was little association of attacks of breathlessness and wheeze with mortality in the 
stratified analyses. 
 
The findings in the present study are largely in agreement with previous studies of respiratory 
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symptoms with shorter duration of follow up [5-8, 22-26], including studies in elderly populations 
[27, 28].  
 
The increasing HR for death with ordinal ratings of respiratory symptoms in this study is consistent 
with previous reports for graded dyspnoea with 43 years of follow up [29], with increasing HR with 
increasing number of respiratory symptoms in 30-year follow up the Oslo county cohort 1972 [6] 
and 12-year follow up in the 1995 Nord-Trøndelag county health study [10]. The latter study used a 
similar questionnaire and adjusted for age, smoking, education, lung function, body mass index, 
physical activity and cardiovascular disease in men and women [10]. The present study was larger, 
covered several geographical regions and had a longer observation time than previous Norwegian 
studies. We adjusted for breathlessness on effort, cough and phlegm and attacks of 
breathlessness or wheeze in multivariable analysis, in contrast the previous studies that assessed 
the impact of the symptom groups separately or in fixed combinations [8]. Our findings support the 
recent findings of a gradient of HR for all-cause mortality with increasing number of chronic 
respiratory symptoms in a cohort of more than 80,000 subjects in the general population with 
normal spirometry and without known airway disease [30].  
 
Important confounders for the association for respiratory symptoms and outcome were smoking, 
education and occupational exposure to air pollution. We controlled for these three factors at 
baseline; however, smoking habit as well as occupational exposures may have changed during 
follow-up, and respiratory symptoms may improve over time [31]. It is thus possible that there is 
residual confounding by smoking. 
 
As we did not have information on cumulative smoking habits measured in pack-years, we chose 
daily tobacco consumption at baseline in the analyses. After 1970, smoking has declined in all 
cohorts of men and women in Norway [32]. In 1973, 53 % of men and 32 % of women aged 16–74 
years were daily smokers, in contrast to 11 % and 10 % in 2017, respectively [33]. Therefore, some 
of the respondents who smoked and reported symptoms might have had fewer symptoms when 




The pattern of an increasing HR for deaths with increasing cough and phlegm score was of similar 
size in the cohorts until 1990. The lack of association between respiratory symptoms and risk of 
deaths in the later 1998–1999 cohort may be attributed to a larger fraction (45 %) of never smokers 
in this cohort than the earlier ones.  
 
We found for breathlessness on effort no effect modification among never smokers, ex-smokers, 
and ever smokers. However, for cough and phlegm the risk was unambiguous in current smokers, 
but not present in never smokers or ex-smokers.  
The questions on cough and phlegm cover both acute and chronic symptoms. It is possible that a 
larger fraction of acute symptoms were due to viral or allergic diseases in non-smokers, than in 
current smokers or ex-smokers with smoking-induced chronic symptoms. The biology of airways 
inflammation may thus differ in smokers and non-smokers. 
The symptom group of attacks of breathlessness and wheezing showed no association with 
mortality in either group of smoking habits. This supports previous findings in a general population 
cohort with 43 years of follow up [29].  
 
Strength of the present study were the large population-based sample, length of follow-up and 
completeness of data, which enabled us to analyse subgroups of gender, smoking habits, age 
groups, education, occupational exposure, area of living and follow-up time. All-cause mortality is a 
robust outcome, and the Cause of Death Registry in Norway is complete and of good quality [35]. 
Furthermore, the self-reported symptoms are unaffected by interviewer variability. Questionnaires 
on respiratory symptoms are feasible for inclusion in epidemiological studies [36] and the simplicity 
of a questionnaire enables the use in general practice. 
 
The participation rate in the study was high [1], and much higher than most studies are able to 
achieve today. Therefore, we think the sample is reasonably representative of the general 
population in these areas. However, non-response was not at random and there were clearly some 
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differences in characteristics between respondents and non-respondents to the survey. We are not 
aware of any change in the linguistic meaning of each respiratory symptom from 1972 to 1998. 
 
Some weaknesses of the study are the lack of adjustment for lung function, body mass index and 
physical activity and changes over time in factors like smoking and occupational exposures to air 
pollution. However, respiratory symptoms predict death independent of lung function [8, 9, 36].  
 
The lack of persistence of respiratory symptoms is well known from previous studies. The 
persistence of answers is greater for breathlessness on effort than for cough and wheezing [18, 31, 
37, 38]. 
 
Another challenge of asking about respiratory symptoms is that differences may exist in the 
meaning of the questions. However, our findings have been documented for two regions and is 
most probably valid for Norway as all persons use identical language. 
 
The mechanisms for the associations between respiratory symptoms is not clear and may be 
explained in different ways. For example, the respiratory symptoms may be indicators of 
inflammatory disease in pulmonary, cardiovascular and other organs, or of neoplastic diseases in 
the lung and other organs. 
 
This study used time on study as the time variable in the Cox models and adjusted for age at 
baseline. Some authors have suggested instead using age as the time variable in cohort studies 
[39, 40]; however, others recommend the approach used in the present study or that this would 
only marginally influence the results [41, 42].  
 
Respiratory symptoms are simple and cheap to collect and represent major reasons to contact 
health professionals. Such symptoms are strongly associated with mortality, as shown in this 
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paper. Such measures could be further refined and tested for use in the assessment and 
monitoring of management of respiratory diseases.  
 
In summary, respiratory symptoms of breathlessness, cough and phlegm were associated with 
deaths up to 45 years after baseline recording. The findings were observed across cohorts and 
subgroups after adjustment for age, sex, smoking habits, educational level, and occupational 
exposure to air pollution. This supports the robustness of the findings. 
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Table 1. Flowchart of random sampled individuals in the study of respiratory symptoms and all cause deaths 
in Norway 
 






















4992 112235 25000 162225 
Persons in more 
than one sample 
and thus 
excluded in later 
samples 
1*  2 1893 1627 3523 
Available for  
study 







19892 4982 108812 23210 156896 
Respondents 
(response to at 
least 1 of 17 
questionnaire 
items) 
17690 4461 77003 15870 115024 
Respondents to 
smoking habits 










16445 4307 71958 14765 107475 




Table 2. Questions (Q) on respiratory symptoms and scores 
 
Respiratory symptom group Questions, score 
Cough and phlegm (Bronchitis like 
symptoms), scores 0-5 
Q 8. Do you usually cough and clear your throat in the morning? 
Yes=1, no=0. 
 Q 9. Do you usually cough during the day? Yes=1, no=0. 
 Q 10. When you cough or clear your throat, do you usually bring up 
phlegm? Yes=1, no=0. 
 Q 11. Do you have cough for 3 months or more altogether during a 
year? Yes=1, no=0. 
 Q 12. During the last 2 years, have had a cough and/or phlegm in 
connection with a cold for more than 3 weeks? Yes=1, no=0. 
Attacks of breathlessness and wheeze 
(Asthma like symptoms), scores 0-2 
Q 17. Do you have attacks of breathlessness? Yes=1, no=0. 
 Q 18.Have you ever had wheezing in your chest? Yes=1, no=0. 
Breathless, scores 0-4 Q 13. Are you more breathless than people of your own age when 
walking uphill? Yes=1, no=0. 
 Q 14. Are you breathless when you climb two flights of stairs at an 
ordinary pace? Yes=1, no=0. 
 Q 15. Are you breathless when you walk on level ground at an 
ordinary pace? Yes=1, no=0 






Table 3. Number (percentages) of persons by age, sex, education, smoking habits and occupational exposure to air pollution and overall 



















Number of deaths 
  N % N % N % N % N % N % 
Age             
15-29 yrs 5706 32 1482 34 954 1 4641 30 12783 11 903 7 
30-44 yrs 3710 21 1330 30 29944 39 5433 35 40417 35 5036 12 
45-59 yrs 5130 29 893 20 22864 30 3730 24 32617 29 14473 44 
60-75 yrs 3134 18 699 16 22911 30 1819 12 28563 25 25423 89 
Sex             
Male 8150 46 2209 50 71840 94 6944 44 89143 78 37127 42 
Female 9530 54 2195 50 4833 6 8679 56 25237 22 8708 35 
Highest attained education             
Compulsory education (<11 yrs) 5869 34 1044 24 21015 28 1585 11 29513 26 19108 65 
Medium level (11-13 yrs) 8309 48 2342 54 40153 53 7396 49 58200 52 21651 37 
University level (14+ yrs) 3199 18 961 22 14238 19 6013 40 24411 22 4442 18 
Smoking habits             
Never smokers 6561 37 1801 41 23250 30 7087 45 38699 34 12059 31 
Ex-smokers 2258 13 840 19 24206 32 3372 22 30676 27 13842 45 
Smokers 8861 50 1763 40 29217 38 5164 33 45005 39 19934 44 
Tobacco smoked (g) per day              
1-9 2773 30 599 25 11157 23 1992 26 16521 24 7848 48 
10-19 4654 50 1254 53 24652 50 3678 48 34238 50 14055 41 
20+ 1868 20 525 22 13714 28 2033 26 18140 26 7719 43 
Occupational exposure to air pollution            
Yes 3226 19 1279 29 37721 52 6150 40 48376 44 18954 39 
None 13504 81 3084 71 35411 48 9233 60 61232 56 24032 39 




Table 4. Number (percentage) of persons by symptom score for breathless, cough and/or phlegm and attacks of breathless and/or wheeze in four cohorts. 
 
 









cohort 1998–1999 Total 
  N % N % N % N % N % 
Breathless on effort, score           
0 14358 81 3568 81 61182 80 11983 77 91091 80 
1 1677 9 481 11 8055 11 1868 12 12081 11 
2 1006 6 266 6 5148 7 1249 8 7669 7 
3 452 3 60 1 1746 2 395 3 2653 2 
4 187 1 29 1 542 1 128 1 886 1 
Cough and phlegm, score           
0 10569 60 2529 57 53172 69 8004 51 74274 65 
1 3182 18 897 20 12862 17 3523 23 20464 18 
2 1746 10 409 9 4696 6 1626 10 8477 7 
3 972 5 290 7 2726 4 1103 7 5091 4 
4 666 4 163 4 1860 2 764 5 3453 3 
5 545 3 116 3 1357 2 603 4 2621 2 
Attacks of breathlessness and wheeze, score           
0 13148 77 3183 75 55559 76 10622 69 82512 75 
1 2976 17 721 17 12784 17 3035 20 19516 18 
2 1058 6 320 8 4746 6 1633 11 7757 7 





Table 5. Number (percentage) of persons by symptom score for breathless, cough and/or phlegm and attacks of breathless and/or wheeze according to 
smoking status. 
 
 Never smoker Ex-smoker Current smoker 
  N % N % N % 
Breathless on effort, score       
0 33320 86 24242 79 33529 75 
1 2829 7 2951 10 6301 14 
2 1809 5 2255 7 3605 8 
3 567 1 951 3 1135 3 
4 174 0 277 1 435 1 
Cough and phlegm, score       
0 28993 75 22686 74 22595 50 
1 6039 16 4878 16 9547 21 
2 1758 5 1468 5 5251 12 
3 984 3 771 3 3336 7 
4 554 1 485 2 2414 5 
5 371 1 388 1 1862 4 
Attacks of breathlessness and wheeze, score       
0 31812 86 23106 79 27594 64 
1 3741 10 4388 15 11387 26 






Table 6. Hazard ratios (HR) of death1 with 95% confidence intervals (CI) and p-values by respiratory symptoms separately in the four cohorts, multivariable 
proportional hazards regression analysis. 
 
Oslo county cohort 
1972 




ity, Rogaland county 
cohort 1988–1990 
Oslo and Hordaland 
counties cohort 
1998–1999 
  HR 95%CI HR 95%CI HR 95%CI HR 95%CI 
Breathless on effort, score         
0 1  1  1  1  
1 1.22*** [1.14,1.31] 1.16 [0.97,1.40] 1.30*** [1.25,1.35] 1.29** [1.10,1.52] 
2 1.49*** [1.37,1.62] 1.45*** [1.18,1.79] 1.52*** [1.46,1.59] 1.56*** [1.33,1.84] 
3 1.59*** [1.41,1.79] 2.27*** [1.60,3.23] 1.95*** [1.83,2.08] 2.41*** [1.92,3.01] 
4 1.47*** [1.23,1.75] 1.58 [0.98,2.56] 1.91*** [1.71,2.13] 2.18*** [1.51,3.14] 
Cough and phlegm, score         
0 1  1  1  1  
1 1.04 [0.99,1.11] 1.13 [0.97,1.33] 1.02 [0.99,1.06] 1 [0.87,1.16] 
2 1.08* [1.01,1.16] 1.18 [0.96,1.46] 1.10*** [1.05,1.16] 1.06 [0.89,1.26] 
3 1.27*** [1.16,1.39] 0.99 [0.78,1.25] 1.20*** [1.13,1.27] 0.91 [0.74,1.13] 
4 1.35*** [1.21,1.51] 1.44* [1.06,1.97] 1.15*** [1.07,1.23] 1.03 [0.82,1.28] 
5 1.31*** [1.16,1.47] 1.35 [0.96,1.88] 1.30*** [1.21,1.41] 1.13 [0.88,1.46] 
Attacks of breathlessness and wheeze, score         
0 1  1  1  1  
1 1 [0.95,1.06] 1.12 [0.95,1.32] 1.03* [1.00,1.07] 1.01 [0.88,1.16] 
2 1.06 [0.97,1.17] 1.06 [0.84,1.33] 1.10*** [1.05,1.16] 1.04 [0.86,1.25] 
N 16084   4137   69172   14499   
1 Adjusted for age, sex, education , smoking habits and occupational exposure, in addition to the various respiratory symptoms;  




Table 7. Hazard ratios (HR) of death with 95% confidence intervals (CI) and p-values by respiratory symptoms in the pooled cohorts, multivariable propor-
tional hazards regression analysis. 
         
 All,  adj. for age/sex
1 All 2 Men 3 Women  3 
  HR 95%CI HR 95%CI HR 95%CI HR 95%CI 
Breathless on effort, score         
0 1  1  1  1  
1 1.32*** [1.28,1.36] 1.28*** [1.24,1.32] 1.32*** [1.27,1.36] 1.11** [1.03,1.19] 
2 1.51*** [1.46,1.56] 1.52*** [1.47,1.57] 1.55*** [1.49,1.62] 1.36*** [1.26,1.48] 
3 1.85*** [1.75,1.94] 1.90*** [1.80,2.00] 2.00*** [1.89,2.12] 1.52*** [1.35,1.72] 
4 1.75*** [1.60,1.90] 1.78*** [1.63,1.95] 1.92*** [1.74,2.13] 1.39*** [1.16,1.68] 
Cough and phlegm, score         
0 1  1  1  1  
1 1.09*** [1.07,1.12] 1.03* [1.00,1.06] 1.04* [1.01,1.07] 1.02 [0.96,1.09] 
2 1.26*** [1.22,1.31] 1.10*** [1.06,1.14] 1.10*** [1.05,1.14] 1.13** [1.03,1.23] 
3 1.38*** [1.32,1.44] 1.19*** [1.14,1.25] 1.22*** [1.16,1.29] 1.09 [0.98,1.21] 
4 1.44*** [1.37,1.52] 1.20*** [1.13,1.27] 1.18*** [1.11,1.26] 1.28*** [1.12,1.46] 
5 1.55*** [1.47,1.65] 1.28*** [1.21,1.37] 1.30*** [1.22,1.39] 1.20* [1.03,1.39] 
Attacks of breathlessness and wheeze, score       
0 1  1  1  1  
1 1.10*** [1.07,1.12] 1.03* [1.00,1.06] 1.02 [0.99,1.05] 1.07 [1.00,1.14] 
2 1.11*** [1.07,1.16] 1.09*** [1.05,1.14] 1.08** [1.03,1.13] 1.14** [1.04,1.26] 
N 109785   103881   81510   22371   
1 Adjusted for age, sex, study cohort and the various respiratory symptoms      
2 Adjusted for age, sex, education , smoking habits, occupational exposure and study cohort, in addition to the various respiratory symptoms 
3 Adjusted for age, education , smoking habits, occupational exposure and study cohort, in addition to the various respiratory symptoms 







Fig.1. Survival over 45 years according to respiratory symptoms, defined as no. of affirmative responses to items on (a) Breathlessness 










































Suppl. Table 1. Hazard ratios with 95% confidence intervals and p-values in the pooled cohort according to response in survey, multivariable 
proportional hazards regression analysis with shared frailty for study cohort. 
 
 
Pooled cohort  
  HR 95%CI 
Response status 
Non-respondents 1 [1.00,1.00] 
Respondents 0.64*** [0.63,0.65] 
Gender   
Male 1 [1.00,1.00] 
Female 0.59*** [0.58,0.61] 
Age, per year 1.11*** [1.11,1.11] 
Highest attained education   
Compulsory education (<11 yrs) 1 [1.00,1.00] 
Medium level (11-13 yrs) 0.84*** [0.82,0.85] 
University level (14+ yrs) 0.51*** [0.50,0.53] 
N 151174   
* p<0.05, ** p<0.01, *** p<0.001 






Suppl. Table 2. Hazard ratios with 95% confidence intervals and p-values in pooled cohorts, stratified according to length of education. 
Multivariable proportional hazards regression analysis1. 
               
 <11 years 11–13 years >13 years   
  HR 95%CI HR 95%CI HR 95%CI   
Breathless on effort, score         
0 1  1  1    
1 1.25*** [1.19,1.31] 1.32*** [1.26,1.38] 1.23*** [1.10,1.37]  
2 1.51*** [1.44,1.59] 1.52*** [1.44,1.60] 1.57*** [1.37,1.80]  
3 1.86*** [1.73,2.00] 1.96*** [1.81,2.12] 1.89*** [1.45,2.45]  
4 1.78*** [1.58,2.00] 1.82*** [1.57,2.09] 1.75* [1.03,2.99]  
Cough and phlegm, score         
0 1  1  1    
1 1.02 [0.98,1.06] 1.05* [1.01,1.09] 0.99 [0.91,1.08]  
2 1.15*** [1.08,1.22] 1.06* [1.01,1.12] 1.09 [0.96,1.23]  
3 1.18*** [1.10,1.26] 1.19*** [1.12,1.28] 1.27** [1.07,1.51]  
4 1.14** [1.05,1.24] 1.24*** [1.14,1.34] 1.42*** [1.16,1.73]  
5 1.22*** [1.11,1.34] 1.34*** [1.23,1.47] 1.28* [1.01,1.61]  
Attacks of breathlessness and wheeze, score        
0 1  1  1    
1 1.01 [0.97,1.05] 1.03 [0.99,1.07] 1.12* [1.03,1.23]  
2 1.06 [1.00,1.13] 1.09** [1.03,1.16] 1.26** [1.09,1.46]   
N 25950   54390   23541     
* p<0.05, ** p<0.01, *** p<0.001         
1 Adjusted for age, sex, smoking history, occupational exposure and study cohort, in addition to the various respiratory symptoms 
  
 
Suppl. Table 3. Hazard ratios with 95% confidence intervals and p-values in pooled cohorts, stratified according to smoking status. 
Multivariable proportional hazards regression analysis. 
               
 Never-smokers1 Ex-smokers2 Current-smokers2   
  HR 95%CI HR 95%CI HR 95%CI   
Breathless on effort, score         
0 1  1  1    
1 1.26*** [1.17,1.35] 1.26*** [1.19,1.34] 1.27*** [1.22,1.33]  
2 1.50*** [1.39,1.62] 1.52*** [1.42,1.62] 1.46*** [1.38,1.54]  
3 1.80*** [1.59,2.05] 1.92*** [1.75,2.11] 1.89*** [1.74,2.06]  
4 1.42** [1.14,1.78] 2.24*** [1.90,2.64] 1.63*** [1.43,1.87]  
Cough and phlegm, score         
0 1  1  1    
1 0.93** [0.87,0.98] 1.05 [1.00,1.11] 1.05* [1.01,1.10]  
2 1.07 [0.97,1.18] 0.99 [0.91,1.09] 1.12*** [1.07,1.18]  
3 0.93 [0.82,1.05] 1.05 [0.93,1.18] 1.27*** [1.19,1.35]  
4 0.93 [0.78,1.11] 1.15 [1.00,1.32] 1.23*** [1.14,1.31]  
5 1.04 [0.86,1.27] 1.43*** [1.23,1.67] 1.27*** [1.18,1.37]  
Attacks of breathlessness and wheeze, score        
0 1  1  1    
1 1.02 [0.95,1.09] 1.02 [0.96,1.07] 1 [0.96,1.04]  
2 1.11 [0.99,1.23] 1.06 [0.98,1.16] 1.05 [0.99,1.11]   
N 34916   24969   38253     
* p<0.05, ** p<0.01, *** p<0.001         
1 Adjusted for age, sex, education, occupational exposure and study cohort, in addition to the various respiratory symptoms 




Suppl. Table 4. Hazard ratios with 95% confidence intervals and p-values in pooled cohorts, stratified according to age. Multivariable proportional 
hazards regression analysis1. 
                 
 15–29 years 30–44 years 45–59 years 60–75 years 
  HR 95%CI HR 95%CI HR 95%CI HR 95%CI 
Breathless on effort, score         
0 1 [1.00,1.00] 1 [1.00,1.00] 1 [1.00,1.00] 1 [1.00,1.00] 
1 1.14 [0.91,1.43] 1.23*** [1.12,1.35] 1.33*** [1.26,1.40] 1.31*** [1.25,1.36] 
2 2.01*** [1.51,2.67] 1.43*** [1.26,1.62] 1.61*** [1.50,1.72] 1.59*** [1.52,1.67] 
3 0.58 [0.19,1.83] 1.85*** [1.45,2.35] 1.99*** [1.80,2.21] 2.10*** [1.97,2.24] 
4 3.77** [1.51,9.40] 0.97 [0.67,1.42] 1.80*** [1.53,2.12] 1.95*** [1.74,2.19] 
Cough and phlegm, score         
0 1 [1.00,1.00] 1 [1.00,1.00] 1 [1.00,1.00] 1 [1.00,1.00] 
1 1.05 [0.87,1.27] 1.11* [1.02,1.20] 1.01 [0.96,1.06] 1.02 [0.99,1.06] 
2 1.33* [1.06,1.66] 1.23*** [1.11,1.37] 1.10** [1.03,1.18] 1.09** [1.03,1.15] 
3 1.05 [0.77,1.42] 1.37*** [1.20,1.56] 1.22*** [1.13,1.32] 1.12** [1.04,1.19] 
4 1.36 [0.98,1.89] 1.47*** [1.26,1.71] 1.23*** [1.12,1.35] 1.10* [1.02,1.19] 
5 1.11 [0.72,1.71] 1.76*** [1.49,2.09] 1.36*** [1.23,1.51] 1.15** [1.06,1.26] 
Attacks of breathlessness and wheeze, score        
0 1 [1.00,1.00] 1 [1.00,1.00] 1 [1.00,1.00] 1 [1.00,1.00] 
1 1.02 [0.85,1.24] 1.03 [0.95,1.11] 1.06* [1.01,1.11] 0.99 [0.95,1.03] 
2 1.04 [0.78,1.39] 1.04 [0.93,1.17] 1.07* [1.00,1.15] 1.02 [0.97,1.09] 
N 11832   37817   29613   24619   
* p<0.05, ** p<0.01, *** p<0.001         
1 Adjusted for sex, education , smoking habits, occupational exposure and cohort, in addition to the various respiratory symptoms 
 
